Today's Hours: 8:00am - 8:00pm

Search

Did You Mean:

Search Results

  • Book
    volume editor, Claudio Ronco.
    Contents:
    Expanded hemodialysis : a new concept therapy / X. Yu
    Middle-molecule uremic toxins and outcomes in chronic kidney disease / Z.A. Massy, S. Liabeuf
    Uremia retention molecules and clinical outcomes / F. Carvalho Barreto, D. Veit Barreto, M.E.F. Canziani
    End-stage renal disease, inflammation, and cardiovascular outcomes / L. Dai, E. Golembiewska, B. Lindholm, P. Stenvinkel
    The cardiovascular burden in end-stage renal disease / M. Cozzolino, A. Galassi, F. Pivari, P. Ciceri, F. Conte
    Inflammation and protein-energy wasting in the uremic milieu / M. Jankowska, G. Cobo, B. Lindholm, P. Stenvinkel
    Inflammation : a key contributor to the genesis and progression of chronic kidney disease / Q. Qian
    Solute transport in hemodialysis : advances and limitations of current membrane technology / W.R. Clark, D. Gao, M. Neri, C. Ronco
    Membrane innovation in dialysis / A. Boschetti-de-Fierro, W. Beck, H. Hildwein, B. Krause, M. Storr, C. Zweigart
    Multidimensional classification of dialysis membranes / C. Ronco, M. Neri, A. Lorenzin, F. Garzotto, W.R. Clark. Modeling of internal filtration in TheraNova hemodialyzers / A. Lorenzin, M. Neri, W.R. Clark, F. Garzotto, A. Brendolan, F. Nalesso, N. Marchionna, M. Zanella, M. Sartori, G.B. Fiore, C. Ronco
    The rational for extended haemodialysis therapy (HDx) / C.A. Hutchison, M. Wolley
    Expanded hemodialysis therapy : prescription and delivery / N. Heyne
    Effects of hemodialysis therapy using dialyzers with medium cut-off membranes on middle molecules molecules / A.H. Kirsch, A.R. Rosenkranz, R. Lyko, D.H. Krieter
    The place of large pore membranes in the treatment portfolio of patients on hemodialysis / W. Van Biesen, R. Vanholder, E. Schepers, G. Glorieux, A. Dhondt, S. Eloot
    Large middle molecules and albumin removal : why should not we rest on our laurels? / N. Florens, L. Juillard
    Effects of expanded hemodialysis therapy on clinical outcomes / S. Mitra, K. Kharbanda.
    Digital Access Karger 2017
  • Article
    Homer LD, Small A.
    Am J Physiol. 1977 Sep;233(3):H350-5.
    A model incorporating the effects of recirculation time lag, cardiac output, clearance, volume of distribution, and the variance of the distribution of recirculation times is applied to the analysis of indicator dilution curves. Experiments on dogs with use of radioactively labeled diethylenetriaminepentaacetic acid were done to evaluate the model. This five-parameter model can be fitted to data obtained during the period from less than 1 min to 3 h after a single injection of indicator. Estimates of cardiac output and clearance are in satisfactory agreement with estimates obtained by alternative techniques. Estimates of the time lag and volume of distribution are of physiologically plausible magnitude. The variance of the distribution of recirculation times is a new parameter, of which the possible usefulness to physiologists is discussed.
    Digital Access Access Options